Hims & Hers Health Q1 Earnings Call Highlights

Hims & Hers Earnings Preview: The Novo Nordisk Shift Puts GLP-1 Strategy in FocusHims & Hers Health (NYSE:HIMS) reported first-quarter 2026 revenue growth and raised its full-year revenue outlook, while executives said a strategic shift in the company’s weight-loss business is cr